Ozempic-maker Novo Nordisk slims down to ‘Novo’

It will keep the full Novo Nordisk as its legal corporate name, using Novo and an updated version of its bull logo for its packaging

Danish pharmaceuticals giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced on Monday a name change to just Novo, hoping it will be more “memorable and relevant” for clients.

The rebrand comes ahead of a strategic presentation on September 21, when executives are to lay out their plan for “a faster, more competitive and increasingly consumer-driven market”.

The company is battling fierce competition in the anti-obesity sector, where its hugely successful Ozempic and Wegovy treatments have spurred rivals to catch up.

It released a new tablet form of Wegovy in the United States in January, and the pill was recently approved for use in Europe.